Home
GSC Biological and Pharmaceutical Sciences
Peer-reviewed Journal | Impact factor 8.1 | ISSN: 2581-3250 | CAS Source Indexed | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September 2026 - Vol. 36, Issue 3 

🌟 GSC Biological and Pharmaceutical Sciences (GSCBPS) 🌟

Low Publication Charges | Fast Editorial Processing | Crossref DOI Linking | Transparent Peer-Review Process

Publishing quality research in Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare and Allied Life Sciences.

e-ISSN: 2581-3250 | Impact Factor: 8.1 | Established: 2017 | Charges: USD 35 / INR 2100

📄 Submit Manuscript 👉 Author Guidelines 📚 Published Articles 

Changes of the endothelial properties in patients with coronary artery disease after COVID-19

Breadcrumb

  • Home
  • Changes of The Endothelial Properties In Patients With Coronary Artery Disease After COVID-19
  • Changes of the endothelial properties in patients with coronary artery disease after COVID-19

Shakboz Abbosovich Ubaydullaev * and Anis Lutfullaevich Alyavi

Republican Specialized Scientific Practical Medical Center of Therapy and Medical Rehabilitation, Tashkent, Uzbekistan.
Research Article
GSC Biological and Pharmaceutical Sciences, 2022, 21(02), 269-273.
Article DOI: 10.30574/gscbps.2022.21.2.0440
DOI url: https://doi.org/10.30574/gscbps.2022.21.2.0440
Received on 12 October 2022; revised on 21 November 2022; accepted on 23 November 2022
COVID-19, like other respiratory viruses, has extra pulmonary manifestations. Like other organs cardiovascular system suffers from the virus. In particular, exposure to the virus leads to damage to the cardiovascular system (CVS), the pathophysiological mechanisms of which are not completely clear; a full understanding of the mechanisms of interaction between COVID-19 and CVS has not been formed. The article analyzes current ideas about COVID-19, considers possible links in pathogenesis, attempts to systematize the pathophysiological mechanisms of CVS damage and their complications, analyzes the relationship with cardiovascular comorbidity, and describes the features of pathomorphology and a hypothetical long-term prognosis. The presented information can contribute to understanding the two-way interaction of cardiovascular diseases and the effects of COVID-19 in order to develop effective preventive measures and make the right decision in choosing a therapeutic tactic for a patient within a systematic approach.
Cardiovascular system; Pathogenesis of COVID-19 damage; Angiotensin-converting enzyme-2; Renin-angiotensin system; Endothelial dysfunction; Microcirculation; Hemostasis system
https://gscbps.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCBPS-2022-…

Preview Article PDF

Shakboz Abbosovich Ubaydullaev and Anis Lutfullaevich Alyavi. Changes of the endothelial properties in patients with coronary artery disease after COVID-19. GSC Biological and Pharmaceutical Sciences, 2022, 21(2), 269-273. Article DOI: https://doi.org/10.30574/gscbps.2022.21.2.0440


📝 Copyright, Licensing and Permissions: © Copyright Author(s). This article is published under the 🌐 Creative Commons Attribution 4.0 International License (CC BY 4.0) , which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are properly credited, a link to the license is provided, and any changes made are indicated.


⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.


🏆 Get Publication Certificate 📄 Download Letter of Acceptance 🔗 Verify Crossref DOI 📘 View Issue Cover Page 👨‍🔬 Editorial Board 📑 Table of Contents 

🚀 Publish Your Research in International Peer Reviewed Open Access Journal - GSC Biological and Pharmaceutical Sciences (GSCBPS)

Submit your manuscripts from Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare, Biotechnology and Allied Life Sciences etc.

🌍 International Journal   |   👨‍🔬 Transparent Peer Review Process   |   🌐 Open Access Publishing   |   🔗 Crossref DOI 
⚡ Fast Editorial Processing   |   💰 Low Publication Charges

📝 Submit Your Manuscript 📘 Author Guidelines 💰 Publication Charges 

✅ No Submission Fee •  📜 Free Publication Certificate • 🌍 Global Visibility

⭐ Popular Pages


  • 🌍 International Journal
  • 🌐 Open Access Journal
  • 👨‍⚖️ Peer-Reviewed Journal
  • 💰 Low APC Journal
  • 🚀 Fast Publication Journal
  • ⚡ Fast-Track Peer-Review
  • 🔗 Crossref DOI Journal
  • 📖 Refereed Journal
  • 📈 High Impact Journal
  • 🧬 International Biology Journal
  • 💊 International Pharmacy Journal
  • 📝 Publish Research Paper

✍️ Author Resources


  • 📝 Publish Research Paper
  • 📖 Author Guidelines
  • 🎯 Aims and Scope
  • 💳 Article Processing Charges
  • 📤 Submit Manuscript
  • 📄 Cover Letter
  • ✍️ Author Declaration Form
  • 📄Track Manuscript Status
  • 📜 Get Publication Certificate
  • 📚 Journal Past Issue Archive
  • 🔎 Journal Indexing

⚖️ Journal Policies


  • ⚖️ Publication Ethics
  • 🛡️ Plagiarism Policy
  • 👨‍🔬 Peer Review Policy
  • 👨‍⚖️ Peer Review Process
  • 📖 Open Access Publishing
  • 📜 Copyright & Licensing
  • 🔗Author Self-Archiving Policy
  • 👥 Authorship Policy
  • 📊 Data Sharing Policy
  • 🤖 AI Usage Policy

Copyright © 2026 GSC Biological and Pharmaceutical Sciences - All rights reserved

Developed & Designed by VS Infosolution